Shaperon Enrolls Its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy ‘Nugel’
210 Patients With Multi-Racial Atopic Dermatitis...Phase 2 Clinical Trial Begins CAMBRIDGE, Mass. & SEOUL, South Korea--(BUSINESS WIRE)--Shaperon, Inc. (Kosdaq: 378800),...

Chinese tape maker Crown New Materials surges 787% in Shenzhen debut, creating paper billionaires
Ekadashi kab hai in 2026: Rama on Nov 5, Devutthana on Nov 20, Papankusha on Oct 22
Navy Court-Martials Captain, Lieutenant Commander Over INS Brahmaputra Capsizing
K.C. Bokadia recalls the stars who never billed producers for staff
SSC CGL Tier 1 Answer Key 2026 Is a Challenge Window, Not a Result 





























